Athira Pharma Long Term Debt

Athira Pharma (ATHA) currently reports a long-term debt of $86K as of June 2026. That compares with $580K in the prior-year period — down 85.1% year over year. Use the charts on this page to explore Athira Pharma's long-term debt history and peer comparisons.

Athira Pharma's long-term debt decreased from $580K to $86K — a 85.1% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Athira Pharma reported $86K in long-term debt as of June 2026. That compares with $580K in the prior-year period — down 85.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $86K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Athira Pharma, and consider following ATHA for alerts when major investors trade the stock.

Athira Pharma is classified in the Healthcare sector. On long-term debt, it currently shows $86K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ATHA with unrelated industries.